Hospira said it has been working with Food and Drug Administration regulators on its quality issues, which have negatively impacted the company’s sales in the last year.
According to the report, Hospira reported a stronger-than-expected 6 percent profit increase in the first quarter. Net income rose to $149.9 million, or 88 cents a share, from $141.7 million, or 84 cents a share, a year earlier.
Read the Chicago Tribune report on Hospira.
Related Articles on Drug Shortages:
American Society of Anesthesiologists Conducts Survey on Drug Shortages
6 Strategies for Surgery Centers to Address Drug Shortages
Sen. Blumenthal Requests GAO Investigation of Drug Shortages
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
